Epithelial development and differentiation in the mammary gland is not dependent on alpha 3 or alpha 6 integrin subunits.

In the mammary gland, both laminin and integrins have been shown to be required for normal ductal morphogenesis during development in vivo, and for functional differentiation in culture models. Major integrin receptors for laminins in the mammary gland are alpha 3 beta 1, alpha 6 beta 1, and alpha 6 beta 4. However, the specific subunits that contribute to laminin-mediated mammary cell function and development have not been identified. In this study, we use a genetic approach to test the hypothesis that laminin-binding integrins are required for the function of the mammary gland in vivo. Rudiments of embryonic mammary gland were shown to develop in the absence of these integrin subunits. Postnatal development of the mammary gland was studied in integrin null tissue that had been transplanted into the mammary fat pads of syngeneic hosts. In mammary epithelium lacking alpha 6 integrin, the beta 4 subunit was not apparent and hemidesmosome formation was only rudimentary. However, despite this deficiency, normal ductal morphogenesis and branching of the mammary gland occurred and myoepithelial cells were distributed normally with respect to luminal cells. Mammary alveoli devoid of alpha 3 or alpha 6 integrin formed in pregnancy and were histologically and functionally identical to those in wild-type mammary gland. The tissue underwent full morphological differentiation, and the epithelial cells retained the ability to synthesize beta-casein. This work demonstrates that mammary tissue genetically lacking major laminin-binding integrin receptors is still able to develop and function.

Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse.

We have examined the role of integrin-extracellular matrix interactions in the morphogenesis of ductal structures in vivo using the developing mouse mammary gland as a model. At puberty, ductal growth from terminal end buds results in an arborescent network that eventually fills the gland, whereupon the buds shrink in size and become mitotically inactive. End buds are surrounded by a basement membrane, which we show contains laminin-1 and collagen IV. To address the role of cell-matrix interactions in gland development, pellets containing function-perturbing anti-beta1 integrin, anti-alpha6 integrin, and anti-laminin antibodies respectively were implanted into mammary glands at puberty. Blocking beta1 integrins dramatically reduced both the number of end buds per gland and the extent of the mammary ductal network, compared with controls. These effects were specific to the end buds since the rest of the gland architecture remained intact. Reduced development was still apparent after 6 days, but end buds subsequently reappeared, indicating that the inhibition of beta1 integrins was reversible. Similar results were obtained with anti-laminin antibodies. In contrast, no effect on morphogenesis in vivo was seen with anti-alpha6 integrin antibody, suggesting that alpha6 is not the important partner for beta1 in this system. The studies with beta1 integrin were confirmed in a culture model of ductal morphogenesis, where we show that hepatocyte growth factor (HGF)-induced tubulogenesis is dependent on functional beta1 integrins. Thus integrins and HGF cooperate to regulate ductal morphogenesis. We propose that both laminin and beta1 integrins are required to permit cellular traction through the stromal matrix and are therefore essential for maintaining end bud structure and function in normal pubertal mammary gland development.

A new in vitro model of murine mesoderm migration: the role of fibronectin and laminin.

Examination of the factors involved in primary mesodermal migration in the mouse has been complicated by the lack of a suitable in vitro model. We have developed a new culture system using primitive streak stage embryos denuded of primitive endoderm, which allows easy observation and manipulation of the outgrowing cells. The cells migrating away from these explants were shown by immunocytochemistry to express vimentin and an epitope of the I antigen recognised by the antibody C6, both of which are present on the newly emerged mesoderm and not on the embryonic ectoderm in sections of embryos in utero. Conversely, cytokeratin, stage-specific embryonic antigen 1 (SSEA-1), E-cadherin and desmoplakin are expressed by the embryonic ectoderm but lost during mesoderm formation in vivo. They are absent or expressed very weakly by the migrated cells in vitro. In addition, only explants of the ectoplacental cone (EPC) and visceral endoderm alone, expressed a carbohydrate epitope (recognised by monoclonal antibody BOO6), characteristic of the EPC and primitive endoderm in utero, but absent from mesoderm. Thus we conclude that the cells which outgrow in this system are indeed mesodermal in phenotype. We have confirmed the work of others in demonstrating the presence of fibronectin (FN) and laminin (LN) in the migratory path of the mesoderm, at the ectoderm-visceral endoderm interface. We also report that the beta 1 integrin subunit of the FN and LN receptor is expressed by mesodermal cells at this interface. Using our in vitro model we have examined the role of the extracellular matrix (ECM) in mesodermal migration. Mesodermal cells migrate further and faster on substrates coated with FN or LN, and this increased migration is abolished by appropriate blocking antibodies. We conclude that the ECM, in particular FN and LN, plays an important role in the migration of primary mesodermal cells during gastrulation in the mouse embryo.